Drug Profile
Research programme: therapeutics - NetVation DL Medicine/Pfizer
Latest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator NetVation DL Medicine; Pfizer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified